Showing 21-28 of 28 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Targeted regulatory T cells to treat type 1 diabetes | Monash University | Joshua Ooi | Cures | 01-February-2023 to 31-January-2026 | $510.000,00 |
| Early Prediction of Progression to Autoimmunity in Type 1 Diabetes | Western Sydney University | Anandwardhan Hardikar | Cures | 01-January-2023 to 31-December-2025 | $875.894,43 |
| Combination immunotherapy with abatacept and nasal insulin | Melbourne Health | John Wentworth | Cures | 01-February-2022 to 30-June-2025 | $575.000,00 |
| Using JAK inhibitors with locally delivered immunosuppression to target islet graft rejection | St. Vincent's Institute of Medical Research | Helen Thomas | Cures | 01-July-2022 to 30-June-2024 | $500.000,00 |
| Examining the Safety and Efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus free features in adults with Type 1 Diabetes | Baker Heart & Diabetes Institute | Neale Cohen | Improving Lives | 01-October-2022 to 28-February-2026 | $746.100,00 |
| Proof of concept trial of intracutaneous islet transplant | Royal Adelaide Hospital | Patrick Coates | Cures | 01-October-2021 to 31-December-2024 | $285.900,00 |
| Australian Type 1 Diabetes Clinical Research Network – General Population Screening Pilot and Feasibility | The University of Sydney | Kirstine Bell | Cures | 01-September-2021 to 31-May-2025 | $989.062,66 |
| α-MSH/MC5R axis as an adjunctive therapeutic target for type 1 diabetes | Monash University | Michael Cowley | Improving Lives | 01-August-2019 to 30-September-2025 | $716.962,40 |